Medication/en: Difference between revisions

Line 256:

===United Kingdom===

In the UK, the Pharmaceutical Price Regulation Scheme is intended to ensure that the [[National Health Service|National Health Service]] is able to purchase drugs at reasonable prices. The prices are negotiated between the Department of Health, acting with the authority of Northern Ireland and the UK Government, and the representatives of the Pharmaceutical industry brands, the [[Association of the British Pharmaceutical Industry|Association of the British Pharmaceutical Industry]] (ABPI). For 2017 this payment percentage set by the PPRS will be 4,75%.

In the UK, the Pharmaceutical Price Regulation Scheme is intended to ensure that the [[:en:National Health Service|National Health Service]] is able to purchase drugs at reasonable prices. The prices are negotiated between the Department of Health, acting with the authority of Northern Ireland and the UK Government, and the representatives of the Pharmaceutical industry brands, the [[:en:Association of the British Pharmaceutical Industry|Association of the British Pharmaceutical Industry]] (ABPI). For 2017 this payment percentage set by the PPRS will be 4,75%.

===Canada===

Line 268:

=== India ===

In India, drug prices are regulated by the [[National Pharmaceutical Pricing Authority|National Pharmaceutical Pricing Authority]].

In India, drug prices are regulated by the [[:en:National Pharmaceutical Pricing Authority|National Pharmaceutical Pricing Authority]].

===United States===

@@ Line 256: / Line 256: @@
 ===United Kingdom===
-In the UK, the Pharmaceutical Price Regulation Scheme is intended to ensure that the [[National Health Service|National Health Service]] is able to purchase drugs at reasonable prices. The prices are negotiated between the Department of Health, acting with the authority of Northern Ireland and the UK Government, and the representatives of the Pharmaceutical industry brands, the [[Association of the British Pharmaceutical Industry|Association of the British Pharmaceutical Industry]] (ABPI). For 2017 this payment percentage set by the PPRS will be 4,75%.
+In the UK, the Pharmaceutical Price Regulation Scheme is intended to ensure that the [[:en:National Health Service|National Health Service]] is able to purchase drugs at reasonable prices. The prices are negotiated between the Department of Health, acting with the authority of Northern Ireland and the UK Government, and the representatives of the Pharmaceutical industry brands, the [[:en:Association of the British Pharmaceutical Industry|Association of the British Pharmaceutical Industry]] (ABPI). For 2017 this payment percentage set by the PPRS will be 4,75%.
 ===Canada===
@@ Line 268: / Line 268: @@
 === India ===
-In India, drug prices are regulated by the [[National Pharmaceutical Pricing Authority|National Pharmaceutical Pricing Authority]].
+In India, drug prices are regulated by the [[:en:National Pharmaceutical Pricing Authority|National Pharmaceutical Pricing Authority]].
 ===United States===